Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Manifestations and Related Risk Factors of Thrombocyte Abnormalities in HIV-Positive Patients Before and After the Initiation of ART.

Infection and drug resistance·2021
Same author

Engineered neutrophil apoptotic bodies ameliorate myocardial infarction by promoting macrophage efferocytosis and inflammation resolution.

Bioactive materials·2021
Same author

Isolation and Culture of Single Microbial Cells by Laser Ejection Sorting Technology.

Applied and environmental microbiology·2021
Same author

Interface-engineered reduced graphene oxide assembly on nanofiber surface for high performance strain and temperature sensing.

Journal of colloid and interface science·2021
Same author

NiCo<sub>2</sub>S<sub>4</sub>nanosheets decorated on nitrogen-doped hollow carbon nanospheres as advanced electrodes for high-performance asymmetric supercapacitors.

Nanotechnology·2021
Same author

Real-time threshold determination of auditory brainstem responses by cross-correlation analysis.

iScience·2021

Related Experiment Video

Updated: Jun 3, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

8.9K

Integrative bioinformatics and immunohistochemical analysis unravel the prognostic significance and immunological

Xin Yu1, Bei Li2, Wenge Li3

  • 1Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, 238 Ziyang Road, Wuhan, 430060, Hubei, People's Republic of China.

Scientific Reports
|January 9, 2025
PubMed
Summary

High LIMCH1 protein expression in breast cancer is linked to poor prognosis and an immunosuppressive tumor microenvironment. This finding highlights LIMCH1 as a potential prognostic indicator and therapeutic target for breast cancer patients.

Keywords:
BioinformaticsBreast cancerLIMCH1Therapeutic targetTumour immunity

More Related Videos

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

6.9K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.4K

Related Experiment Videos

Last Updated: Jun 3, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

8.9K
Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

6.9K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.4K

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • High breast cancer mortality necessitates improved prognostic tools.
  • LIM and calponin homology domain 1 (LIMCH1) protein has dual roles in cancer and warrants investigation.
  • Understanding LIMCH1's function is crucial for developing new breast cancer therapies.

Purpose of the Study:

  • To investigate the expression patterns of LIMCH1 in breast cancer.
  • To analyze the association of LIMCH1 with clinicopathological features, prognosis, and the tumor immune microenvironment (TIME).
  • To explore the molecular mechanisms underlying LIMCH1's role in breast cancer pathogenesis.

Main Methods:

  • Integrative analysis combining The Cancer Genome Atlas (TCGA) bioinformatics data and clinical immunohistochemistry (IHC) cohort data.
  • Exploration of functional annotations and single-cell RNA sequencing (scRNA-seq) data.
  • Development of a nomogram for predicting overall survival rates.

Main Results:

  • High LIMCH1 expression correlates with unfavorable clinical outcomes and serves as an independent prognostic indicator in breast cancer.
  • LIMCH1 is implicated in carcinogenesis and metabolic reprogramming pathways, suggesting its role in tumor progression.
  • LIMCH1 expression is associated with an immunosuppressive TIME, characterized by increased M2 macrophages and decreased CD8+ T cells and NK cells.

Conclusions:

  • LIMCH1 plays diverse roles in breast cancer pathogenesis.
  • LIMCH1 holds potential as a prognostic indicator for breast cancer patients.
  • LIMCH1 represents a potential therapeutic target for breast cancer intervention.